Work Here?
About Kintsugi
Industries
AI & Machine Learning
Healthcare
Company Size
11-50
Company Stage
Series A
Total Funding
$33.5M
Headquarters
Berkeley, California
Founded
2019
Overview
Kintsugi Health develops voice biomarker technology that detects signs of depression and anxiety from short speech clips. This technology helps healthcare providers screen for mental health issues more efficiently and objectively. Kintsugi primarily serves healthcare organizations that take on financial risk for care, such as hospitals and clinics, by offering a tool that can be integrated into their existing systems. Unlike many competitors, Kintsugi focuses on providing a scalable and objective screening method rather than a clinical diagnosis. The company's goal is to make mental healthcare more accessible and equitable, empowering practitioners to better diagnose and monitor mental health conditions.
Simplify's Take
What believers are saying
- Kintsugi's partnership with Wellin5 expands their reach in North America.
- The mental health app market is projected to grow at a 20% CAGR until 2028.
- Regulatory bodies increasingly support AI in mental health diagnostics, boosting Kintsugi's potential.
What critics are saying
- AI algorithm bias could lead to inaccurate mental health assessments.
- The mental health tech market is competitive, with new entrants like Ellipsis Health.
- Data privacy concerns in AI health applications could affect user trust and adoption.
What makes Kintsugi unique
- Kintsugi uses voice biomarkers to detect mental health issues from speech clips.
- Their technology is language agnostic, working across different dialects and accents.
- Kintsugi's AI tool integrates with existing healthcare systems for scalable mental health screening.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$33.5M
Above
Industry Average
Funded Over
0 Rounds
Growth & Insights and Company News
6 month growth
↓ -20%1 year growth
↓ -7%2 year growth
↓ -2%Haritha joins Kintsugi Health with extensive experience in clinical operations, having previously led large-scale SaMD clinical trials as a Clinical Operations Lead at Apple.
Kintsugi receives Frost & Sullivan's 2024 Enabling Technology Leadership Award.
Kintsugi was named 2022 Gartner Cool Vendor in AI Governance and Responsible AI.
CARLSBAD, Calif.--(BUSINESS WIRE)--Wellin5, the premier provider of online counseling, proudly announces a new partnership with Kintsugi, an AI mental health technology leader. This collaboration comes at a time when Wellin5 has successfully navigated the turbulent economic landscape and challenges in the health tech space to thrive and bring this vital partnership to life, setting a new standard in mental health care for over 50,000 clients based in Canada and the USA. “We are immensely proud of this partnership with Kintsugi. It represents not just our resilience and growth in challenging times but also our commitment to innovative solutions in mental health care,” said William Masih, CEO and founder of Wellin5. “This collaboration will significantly enhance our ability to provide empathetic, effective, and data-driven care to our patients.”. Kintsugi's AI-powered tool, Kintsugi Voice, will be integrated into Wellin5’s counseling services, offering a revolutionary mental health screening and monitoring approach
AI mental health tech startup Kintsugi announces partnership with Wellin5.
There are no jobs for Kintsugi right now.
Find jobs on Simplify and start your career today
People Also Viewed
Discover companies similar to Kintsugi
About Kintsugi
Industries
AI & Machine Learning
Healthcare
Company Size
11-50
Company Stage
Series A
Total Funding
$33.5M
Headquarters
Berkeley, California
Founded
2019
There are no jobs for Kintsugi right now.
Find jobs on Simplify and start your career today
People Also Viewed
Discover companies similar to Kintsugi